Friends of Leronlimab
A New Therapeutic Drug for Covid #Leronlimab
  Recent News From CytoDyn
View CytoDyn to Hold Webcast to Provide a Quarterly Company Update
View CytoDyn Announces Resolution of Legal Dispute with Former Chief Medical Officer
View CytoDyn Announces the Addition of Leading Experts in Oncology, Infectious Diseases, and Neuroinflammation to its Scientific Board of Advisors; Dr. Jay Lalezari to Serve as Outside Scientific Advisor
View CytoDyn Announces Publication of Peer-Reviewed Paper, “Suppression of Human and Simian Immunodeficiency Virus Replication with the CCR5-Specific Antibody Leronlimab in Two Species”
View CytoDyn Announces Partial Clinical Hold of HIV Program and Full Clinical Hold of COVID-19 Program
View CytoDyn to Hold Webcast to Provide Company Update
View CytoDyn Announces Leadership Transition Plan to Support Regulatory Approval and Commercialization of Leronlimab
This is a private website & not associated with CYDY, Leronlimab, Vyrologix, CytoDyn or All names, images & website links are the property of their respective owners.
This website is not giving any medical advice.
Do your own research.
Talk to your doctors.
Privacy Term of Service
© 2022